THOMPSON DAVIS & CO., INC. - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 69 filers reported holding ALBIREO PHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q3 2018$42,000
-14.3%
1,262
-9.0%
0.09%
-21.4%
Q2 2018$49,0000.0%1,387
-8.3%
0.12%
-9.3%
Q1 2018$49,000
+716.7%
1,512
+587.3%
0.13%
+821.4%
Q4 2017$6,0002200.01%
Other shareholders
ALBIREO PHARMA INC shareholders Q4 2018
NameSharesValueWeighting ↓
Prosight Management, LP 491,244$9,510,0005.10%
Decheng Capital Management III (Cayman), LLC 623,342$12,068,0004.38%
TANG CAPITAL MANAGEMENT LLC 1,099,516$21,287,0002.61%
Privium Fund Management B.V. 300,252$5,624,0002.04%
Birchview Capital, LP 117,000$2,265,0001.60%
Perceptive Advisors 2,360,139$45,692,0001.33%
Chicago Capital, LLC 1,119,774$21,679,0001.25%
Endurant Capital Management LP 172,621$3,342,0001.09%
Deep Track Capital, LP 1,110,624$21,502,0000.98%
SPHERA FUNDS MANAGEMENT LTD. 359,000$6,950,0000.96%
View complete list of ALBIREO PHARMA INC shareholders